Corporate ActionJun 25, 2026, 04:11 PM
uniQure Closes Public Offering, Raises $259M Gross
AI Summary
uniQure N.V. announced the closing of its previously announced underwritten public offering, raising approximately $259 million in aggregate gross proceeds. The offering included 5,686,813 ordinary shares sold at $45.50 per share, with underwriters fully exercising their option to purchase additional shares. The company intends to use the net proceeds to fund commercialization activities for AMT-130, develop other clinical product candidates, pursue business development, and for general corporate purposes.
Key Highlights
- Closed underwritten public offering of ordinary shares.
- Raised approximately $259 million in aggregate gross proceeds.
- Offered 5,686,813 ordinary shares at a price of $45.50 per share.
- Underwriters fully exercised their option for 741,758 additional ordinary shares.
- Net proceeds to fund commercialization readiness and launches of AMT-130.
- Funds also for development of other clinical product candidates and research projects.
- Proceeds will support business development initiatives and general corporate purposes.
Price Impact
More from QURE